• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Real Estate·OZ
Share

Belpointe PREP, LLC Stocks

$ 37.02Last Updated 15.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

$ 146.26M

$ 37.02
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Belpointe PREP, LLC specializes in the entire lifecycle of commercial real estate properties across the United States, from their initial identification and acquisition to their development, redevelopment, and ongoing management. Furthermore, the company's strategic focus extends to investing in and overseeing a diverse portfolio of real estate-related assets. This includes property-backed loans and mortgages, debt and equity instruments issued by other real estate enterprises, private equity investments, and the tactical acquisition of qualified opportunity funds and businesses within opportunity zones. Belpointe PREP, LLC was founded in 2020 and is headquartered in Greenwich, Connecticut.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.10.2026 16:55

Kazakh Gold and Copper: Why Analysts Believe Arras Minerals Shares Will Rise 160%

16.10.2026 16:24

Love and Hate: Experts Name Stocks to Buy on a Pullback. These Aren't Chipmakers

16.10.2026 15:56

Morning in New York: Rotation Supports the Market Amid AI Challenges

16.10.2026 15:10

European stocks are heading toward their widest gap from U.S. stocks since March

16.10.2026 15:00

IPO City: A biotech company developing "switches" to turn off harmful genes has gone public

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026